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Abstract
Humans with Hermansky-Pudlak Syndrome (HPS) or ocular albinism (OA1) display abnormal aspects of organelle biogenesis.
The multigenic disorder HPS displays broad defects in biogenesis of lysosome-related organelles including melanosomes,
platelet dense granules, and lysosomes. A phenotype of ocular pigmentation in OA1 is a smaller number of
macromelanosomes, in contrast to HPS, where in many cases the melanosomes are smaller than normal. In these studies
we define the role of the Mregdsu gene, which suppresses the coat color dilution of Myo5a, melanophilin, and Rab27a
mutant mice in maintaining melanosome size and distribution. We show that the product of the Mregdsu locus,
melanoregulin (MREG), interacts both with members of the HPS BLOC-2 complex and with Oa1 in regulating melanosome
size. Loss of MREG function facilitates increase in the size of micromelanosomes in the choroid of the HPS BLOC-2 mutants
ruby, ruby2, and cocoa, while a transgenic mouse overexpressing melanoregulin corrects the size of retinal pigment
epithelium (RPE) macromelanosomes in Oa1ko/ko mice. Collectively, these results suggest that MREG levels regulate pigment
incorporation into melanosomes. Immunohistochemical analysis localizes melanoregulin not to melanosomes, but to small
vesicles in the cytoplasm of the RPE, consistent with a role for this protein in regulating membrane interactions during
melanosome biogenesis. These results provide the first link between the BLOC pathway and Oa1 in melanosome
biogenesis, thus supporting the hypothesis that intracellular G-protein coupled receptors may be involved in the biogenesis
of other organelles. Furthermore these studies provide the foundation for therapeutic approaches to correct the pigment
defects in the RPE of HPS and OA1.
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Introduction
These studies define the role of the Mregdsu gene [1], which
suppresses the coat color dilution of Myo5a, melanophilin [2], and
Rab27a [3] mutant mice in maintaining melanosome size and
distribution. Analysis of cellular abnormalities in patients and mice
with HPS reveals that these genes function in biogenesis of
lysosome-related organelle complexes (BLOCS) to mediate vesicle
budding and transport from the trans-Golgi network to nascent
organelles [4,5]. In OA1, defects are limited to melanosomes, and
pathological features are primarily restricted to the eye [6].
Findings suggest that OA1 may function as an intracellular G-
protein coupled receptor regulating both melanosome size and
maturation [7]. Indeed, Gai3 has recently been identified as the
first downstream component in Oa1 signaling in RPE melano-
somes [8]. Individuals with either OA1 or HPS display visual
system defects common to albinism, including reduced visual
acuity and loss of stereoscopic vision from misrouting of retinal
axons at the optic chiasm [7].
Genetic observations of natural mutants, including coat color in
mouse, continue to yield a wealth of information about genes
involved in many processes, including vesicle transport and
organelle formation. Many of these mouse coat color mutants
also display abnormalities of other systems, such as the platelet
dense granule defects in HPS. Melanoregulin loss of function, by
contrast, presents with no observable coat color phenotype, and
the dilute suppressor (dsu) mutation was originally identified as an
unlinked suppressor of the gray coat color of the dilute (Myo5a),
ashen (Rab27a), and leaden (Mlph) mutants [9–11]. Myo5a, Mlph,
and Rab27a act together as a motor complex to mediate
melanosome transport in melanocytes of the skin [12,13]. The
gene encoding the Mregdsu loss of function mutation has been
identified as a vertebrate-specific, highly charged 214 amino acid
protein, without functional domains or homology to other
proteins, but containing a cysteine-rich N-terminal sequence
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suggestive of a membrane binding domain [1]. Melanoregulin
functions in the melanosome transport system in the skin by
influencing transfer of melanosomes from melanocytes to kerati-
nocytes, presumably at the level of the plasma membrane or the
melanosome membrane [1]. Recent studies suggest that melanor-
egulin may act as a cargo receptor in melanosome transport [14],
although the identity of the cargo remains unknown.
Over a dozen genes are involved in HPS in mouse and at least
seven orthologs have been identified in human. Many of these
genes have recently been cloned [15–24]. With the exception of
members of the adaptor protein (AP)-3 and HOPS complexes
known to be involved in vesicle transport, most HPS genes encode
vertebrate-specific proteins with ubiquitous expression and with-
out homology or obvious functional domains. Electron microscopy
studies of skin melanocytes in the various mouse mutants of HPS
have yielded clues as to which genes are required for various stages
of melanosome biogenesis; mutants of genes that act together have
similar phenotypes [25,26]. Yeast two hybrid and co-immunopre-
cipitation studies have confirmed the ultrastructural analyses in
delineating the HPS proteins that interact in specific BLOC
complexes, and showing that HPS3 (cocoa), HSP5 (ruby2J), and
HPS6 (ruby-eyed) are components of BLOC-2 [22,27,28]. HPS3
(cocoa), a member of the BLOC-2 complex, binds to clathrin-
coated vesicles in the cytoplasm of human skin melanocytes [29].
Cytoplasmic transport vesicles appear to be a key component of
organelle, specifically melanosome, biogenesis. Melanogenic pro-
teins are transported to melanosomes using a variety of methods,
including the AP-3 and AP-1 pathways [30], and arrive at different
stages in melanosome development. For example, tyrosinase
relocates from the late endosome directly to stage II melanosomes,
while Pmel17/gp100/silver is transported from AP-3 vesicles to
stage I melanosomes, skipping endosomes altogether [31]. It is
possible that HPS genes of unknown function are involved in the
transport of other components of nascent melanosomes.
Like the HPS genes, Oa1/OA1 was identified by positional
cloning [32–34] and displays structural characteristics typical of
transmembrane G-protein coupled receptors [35]. Further studies
have shown that OA1 indeed functions as an intracellular G-
protein coupled receptor in both Saccharomyces cerevisiae [36] and
mammalian cells [37], and L-DOPA was suggested as a ligand for
OA1 but the signal transduction mechanisms triggered by L-
DOPA is still unclear [38]. OA1 is localized at the membrane of
melanosomes at all stages of maturation but higher amounts are
found in melanosomes at early stages of maturation (stage I and II)
and in late endosomes [39]. Because no spontaneous mutant exists
for Oa1, likely due to the lack of an observable phenotype, a
knockout mouse was created to study its function [40]. This mouse
has features of human ocular albinism (OA1), including the
macromelanosome in pigment epithelium and skin melanocytes a
reduction of melanosome number and a reduced uncrossed retinal
projection [40] [41], similar likewise to humans with oculocuta-
neous albinism and HPS, and similar to other hypopigmented
mouse strains such as Oca1Tyr,c., Hps6ru, Hps2pe, and Hps1ep
[42,43]. Although hypopigmented individuals with RPE melano-
somal abnormalities from many genetic causes share the same
visual system abnormalities, a common mechanism among these
disorders is lacking.
We here provide the first evidence for a molecule that links the
HPS and Oa1 pathways in melanosome biogenesis, and provide
evidence that modulating the levels of melanoregulin can partially
correct the melanosomal defects in the HPS BLOC-2 mutants
Hps6ruby, Hps5ruby2J, and Hps3coa, and in the Oa1 knockout mouse.
Results
Melanoregulin affects eye color of HPS mutants in a
dose-dependent manner
Melanoregulin loss of function suppresses the eye color defect in
ru2J (Hps6ru2J), ruby (Hps5ruby), and cocoa (Hps3cocoa) mice from dark
red to black; overexpression of wildtype melanoregulin lightens the
eye color of these same HPS mutants to red, without affecting coat
color (ruby2 shown in Figure 1A). Melanoregulin loss of function
rescues the eye color in ru2J, ruby, and cocoa mice by increasing
pigmentation of the choroid (Figure 1B–G). Mice carrying the
melanoregulin loss of function (Mregdsu) mutation on a wildtype
background, transgenic mice overexpressing the wildtype melanor-
egulin gene (MregTg), and Oa1 knockout mice have no visible eye or
coat color defects alone or in combination; all have black eyes and
a black coat on a C57BL/6 background (data not shown).
Loss of melanoregulin increases while overexpression
decreases pigment incorporation into melanosomes of
the RPE
In wildtype retinal pigment epithelium, melanosomes constitute
a major component of the cytoplasm, ranging in size and cross-
sectional shape from round to elongated. The width of both long
and round melanosomes is consistently #0.5 mm (Figure 2E). In
melanoregulin loss of function, (labeled dsu), little change is
observed in the cross-sectional area, shape, or size distribution of
melanosomes (Figure 2D), while the average density of melano-
somes is slightly decreased as quantified in Figure 3A. By contrast,
overexpression of melanoregulin via a BAC transgenic on a wild
type background, (labeled Tg) results in a small decrease in both
the average cross-sectional area of RPE melanosomes and density
(Figures 2F and 3A, B). Overall, either loss or overexpression of
melanoregulin has only minor consequences for melanosome size,
shape, and density on an otherwise wildtype background
(Figure 2D–F and Figure 3A–C).
Lack of HPS5 expression results in a drastic decrease in
number, size, and pigmentation of RPE melanosomes in the ru2J
mouse (Figures 2B, 3A). By contrast, loss of Oa1 expression results
in a dramatic increase in the cross-sectional area of many RPE
melanosomes, while others fall within the wildtype size range
(Figure 2H). The average size and pigmentation of these
melanosomes is greatly increased relative to wildtype, while
average number is correspondingly decreased (Figure 3A,B). The
normal elongated shape of melanosomes is strikingly lost in the
Oa1ko/ko mice. While melanosomes vary in size and longest
diameter in approximately the same range as wildtype, very few of
the melanosomes are elongated. Those that reach a diameter
similar to the longest diameter in wildtype mice are almost
invariably round (Figure 2H).
To evaluate how melanoregulin contributes to melanosome
biogenesis, we generated mice carrying Hps5ru2J or Oa1ko/ko alleles
in combination with either two loss of function or two
overexpression alleles of melanoregulin. In the RPE of Hps5ru2J.M-
regdsu (ru2J.dsu) double mutant mice, melanosomes are the same
size, shape, and density as in ru2J mice; however, some
melanosomes appear to be more heavily pigmented (Figures 2A
vs. 2B; 3A vs. 3B). In Hps5ru2J.MregTg (ru2J.Tg) mice, we again find
little effect on melanosome size or shape; however, the number of
pigmented melanosomes is negligible (Figures 2C vs. 2B; 3A,B).
Similarly, in Oa1ko/ko mice, loss of melanoregulin function results
in a decrease in melanosome number along with an increase in
size of the macromelanosomes compared to Oa1 loss of function
alone (Figure 2G vs. 2H; 3A,B). As predicted from the results
presented thus far, overexpression of melanoregulin decreases the
Role of MREG in Melanosome Defects
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average cross-sectional area of the largest melanosomes and also
results in smaller than normal melanosomes (Figure 2I vs. 2H, 2E;
3A,B). In some cells, as shown in Figure 2I, melanoregulin appears
to act in a graded fashion, with a stronger influence on
melanosome size in the apical portion of the cell and a weaker
influence on basal melanosomes.
Together these results show a consistent association between
MREG expression and melanosome biogenesis in the RPE,
whereby loss of melanoregulin function facilitates pigment
incorporation while overexpression results in reduced melaniza-
tion. This function of melanoregulin is most pronounced in the
presence of another mutation that it either suppresses or enhances,
or both, depending on the level of melanoregulin and the function
of the other gene. In the case of Hps5ru2J, loss of melanoregulin has
little effect, whereas overexpression of melanoregulin exacerbates
the lack of melanosome pigmentation (Figure 3C). Conversely, on
an Oa1ko/ko background, melanoregulin loss of function greatly
worsens the macromelanosome phenotype, while overexpression
almost completely rescues the average size and number of RPE
melanosomes (Figure 3C).
Because the size distribution of melanosomes in Oa1.Tg RPE
appears more uneven than in wildtype RPE, the distribution of
melanosome cross-sectional areas was plotted for each of the Oa1-
related mutants compared to wildtype (Figure 3D). Based on this
view of the data, Oa1ko/ko;MregTg (Oa1.Tg) is shown to have a
greater fraction of small melanosomes and also more large
melanosomes than wildtype; however, the distribution is closer
to wildtype in having a smaller fraction of macromelanosomes
than either Oa1ko/ko alone or Oa1ko/ko;Mregdsu (Oa1ko/ko.dsu). The size
distribution for melanoregulin loss of function or overexpression
alone does not vary significantly from wildtype (not shown; Figure
S1).
Melanosome defects in the choroid of HPS5ru2J mice are
rescued by loss of melanoregulin function
The melanosomes in the choroid of wildtype mice are on
average less than half the size (measured as cross-sectional area) of
RPE melanosomes and have a smaller size distribution and higher
density per cell (Figures 4E and 5A,B). Neither loss nor
overexpression of melanoregulin has a substantial effect on size,
Figure 1. Melanoregulin levels modulate the eye color of HPS BLOC-2 mutant mice. A: Three month-old male mice of the genotypes
indicated were photographed in ambient light. Note nearly black color of eyes of Hps5ruby2J.Mregdsu mice, darker than the eyes of Hps5ruby2J mice,
which are darker than those of the light ruby red Hps5ruby2J.MregTg eyes. B–G: Electron micrographs of sections through the RPE and choroid of
Hps6ruby, Hps5ruby2J, and HPS3coa mice, showing the lighter eye color in (A) to be secondary to decreased pigmentation of these layers. Note the effect
of a melanoregulin loss of function (Mregdsu) allele in enhancing pigmentation of the choroid in all three BLOC-2 mutants, Hps6ruby, Hps5ruby2J, and
Hps3coa. Scale bar = 2 mm.
doi:10.1371/journal.pone.0042446.g001
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shape, or density of choroidal melanosomes on an otherwise
wildtype background (Figures 4D,F and 5A,B). In the HPS5ru2J
mutant, the number and size of choroidal melanosomes are
significantly retarded (Figures 4B and 5A,B); melanoregulin
overexpression has almost no effect (Figures 4C and 5A,B), while
melanoregulin loss of function results in a significant increase in
both the size and number of pigmented melanosomes (Figures 4A
and 5A,B). In Oa1ko/ko mice, the situation is a mirror image of
HPS, where loss of melanoregulin has little effect on size or density
of choroidal melanosomes while overexpression results in a slight
rescue of melanosome density (Figures 4H,I,J and 5A,B). Overall,
the results point to an effect of melanoregulin loss of function
facilitating pigment incorporation into maturing melanosomes in
the choroid.
The effects of melanoregulin expression on melanosome
biogenesis in the choroid are not as pronounced as in the RPE,
in that all three Oa1 mutants are more similar to each other than
to melanoregulin loss or overexpression on a wildtype background
(Figure 5C). Even the rescue in HPS5ru2J.dsu leaves this mutant
with more similarity to HPS5ru2J or Hps5ru2J.Tg than to wildtype in
terms of both number and size of melanosomes (Figure 5C). Most
prominently, an evaluation of the size distribution of melanosomes
in the Hps5ru2J mutants reveals a significant correction in the range
of melanosome sizes in Hps5ru2J.dsu compared to either Hpsru2J or
Hps5ru2J.Tg (Figure 5D), which is enough to result in significant
coloration of the eye (Figure 1A).
Melanoregulin protein localizes to cytoplasmic vesicles in
the RPE
Melanoregulin is distributed in the basolateral RPE of wild type
mice as shown in Fig. 6A. Within individual RPE cells
melanoregulin is localized to small cytoplasmic vesicle-like
structures less than 100 mm in diameter (Figure 6B) and [44].
This pattern is similar to that found for transfected HPS3-GFP,
recently found to colocalize with cytoplasmic, clathrin-coated
vesicles in cultured skin melanocytes [29].
Discussion
The reciprocal relationship between the level of melanoregulin
expression and melanosome size suggests that this protein may act
as a negative regulator of membrane fusion, either directly in the
fusion process or indirectly by facilitating the transport of vesicles
(Figure 7). This interpretation is consistent with the findings that
dsu loss of function alone has no grossly visible phenotype, and that
overexpression results in a decrease in melanosome size without
loss of pigmentation. While other forms of albinism affect both skin
(hair follicles) and retinal pigment, the effects of MREG and OA1
appear to be primarily restricted to the eyes. Changes in
melanosomes do occur in hair follicles as well as in eyes of Mregdsu
mutants (R. Rachel, unpublished results). However, these changes
are less clear because the alterations in hair follicles involve not
only melanogenesis but also incorporation of melanin packets into
Figure 2. Size, shape, and density of melanosomes in the RPE of Hps and Oa1 loss of function mouse mutants are altered by loss or
overexpression of melanoregulin. A–I: Electron microscopic images of the RPE in mice of the genotypes indicated. Orientation is with
photoreceptor outer segments toward the top and Bruch’s membrane/choroid toward the bottom of each image. Abbreviations: ru2J =Hps5ru2J;
dsu =Mregdsu; WT=wildtype; Tg =MregTg ; Oa1 =Oa1ko. Scale bar = 1 mm.
doi:10.1371/journal.pone.0042446.g002
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the hair shaft. As such, a specific effect on melanogenesis is not
quantifiable.
Melanoregulin could function in concert with BLOC complexes
transporting vesicles to the early melanosome, by preventing these
transport vesicles from fusing with developing organelles under
certain conditions, e.g., melanosome size or levels of other
proteins. Melanoregulin may serve as a linker molecule between
the BLOC-2 complex and Oa1, which has been shown to regulate
melanosome protein trafficking at early stages of melanosome
biogenesis [39]. Localization of Melanoregulin in cytoplasmic
vesicles may suggest an interaction with Oa1, which regulates
correct targeting of melanosomal protein loaded vesicles to proper
stages of melanosomes during their maturation. This hypothesis is
supported by a series of findings showing a role for OA1 in
melanosome biogenesis via vesicle budding or fusion in the late
endosomal compartment [45–47]. MREG has been localized to
Syn-7 and LAMP-2 rich late endosomal compartments, consistent
with a role in this process [44]. In fact, OA1 loss of function causes
mislocalization of melanosomal protein Tyrp1 in stage I/II
melanosomes causing melanin deposit in not yet mature organelles
[39]. This interpretation is consistent with the recent observation
that Melanoregulin interacts with RILP (p150glued) [14].
These findings have potential implications for treatment for
HPS and OA1 in that inhibition or enhancement of melanor-
egulin, respectively, may be beneficial in modulating the ocular
pigment phenotype of these individuals. What remains to be
determined is the extent to which modulating the pigment phenotype
in each disorder will correct the visual system defects that accompany
it. Interestingly, the melanosomes in both HPS and OA1, irrespective
of being undersized or oversized, cause similar defects in the neural
retina to complete lack of pigment due to loss of the melanogenic
enzyme tyrosinase (for review, see [7]); this suggests that the
melanosome is required for signaling to the neural retina and that
normal melanosome function is important for this signaling, not just
the presence or absence of pigment [48]. This places the melanosome
in a more dynamic role: that of active participant in the function of
the RPE, rather than being a passive medium for light absorption. A
polyacetylene, melanin in intact melanosomes has been shown to
exhibit semi-conductor properties, emitting a flash of light when it
switches from low to high conductivity [49]. This feature suggests that
the conversion of electrical energy to heat or light may provide a
novel mechanism for activation or deactivation of biological
processes. Generalizing the findings with HPS and melanoregulin
linking to OA1 as a size sensor in melanosome biogenesis, we might
expect other G-protein coupled receptors to play similar roles in the
formation of other intracellular organelles.
Experimental Procedures
Materials
Commercially available antibodies were purchased as follows:
anti-MREG mouse mAb, (Novus Biologics) 1:250; anti-alpha
Figure 3. Melanosome density, cross sectional area, and size distribution exhibit a dosage-dependent effect of melanoregulin in
the Oa1 null mouse. Quantitation and analysis of the data shown in Figure 2. Data points are mean values 6 SEM. Note the nearly inverse linear
relationship between melanoregulin expression and A. Melanosome number and B. Melanosome area on an Oa1 null background. On an Oa1
background, both melanosome number and area show a statistically significant change as a function of melanoregulin expression, with p,0.05 as
indicated by asterisks (*). No statistically significant difference was observed in Hps5ru2J mice, p.0.05. Mregdsu mice show a significant decrease in
number of melanosomes, p,0.05 with no change in melanosome area, p.0.05. . C. The number of pigmented melanosomes per field is compared to
the average melanosomal area in wildtype (C57BL6/J) mice. Abbreviations: ru2J =Hps5ru2J; dsu =Mregdsu; WT=wildtype; Tg =MregTg; Oa1=Oa1ko.
doi:10.1371/journal.pone.0042446.g003
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tubulin rabbit pAb (Thermo) 1:200; AlexaFluor 488 donkey anti-
mouse IgG (1:1000); AlexaFluor 594 donkey anti-rabbit (1:1000)
and Hoechst 33258 (1:10,000).
Generation of mouse lines
dsu/dsu, dv/dv mice [11] were obtained from Jackson Labora-
tories and have been maintained at NCI-Frederick for 90+
generations. To obtain mice carrying only the dsu mutation, dsu/
dsu, dv/dv mice were backcrossed to C57Bl/6J for 10 generations,
followed by intercrossing and selecting for mice wildtype at the
dilute locus and carrying dsu/dsu. Some of the data shown here
derives from mice homozygous for dsu at the N5 backcross
generation while the rest is from the N10 backcross line. Crosses
between dsu and ru2J were carried out with B6.dsu mice at the N5
generation, while crosses to Oa1 were done with B6.dsumice at the
N10 generation. Mice were genotyped using the following primers:
Primers for dv: Right, common b7: TCCTCTGTGGTCAT-
CACTGG, Left, wildtype: TGGAATCCCAGCAGTGGTA,
179 bp product. dv, Left, viral allele: CCCGTGTATCCAA-
TAAAGCC, 198 bp product. Primers for dsu: Right, common
dsu59brk-f27 CTGGGAGTTCAAGGTTGGTCTG, Left wild-
type, dsu59brk-b24 GCAGGAGAGGCTGGGAAAAAAC,
230 bp product wildtype, Left dsu, dsu39brk-b CCACAGTCT-
CAAGTCTTTCCTG, dsu ,140 bp. Transgenic mice overex-
pressing wildtype dsu (in the text, Tg) were generated as described
[1]. dsu and Tg alleles were separately bred onto lines of mice
carrying either ru2J (HPS5), ru (HPS6), or coa (HPS3) mutations, or
onto the B6. Oa1ko/ko knockout line. Ru2J/ru2J mice were selected
based on coat color, while Oa1ko/ko mice were genotyped according
to [40]. Mice were housed under cyclic light conditions: 12-h
light/12-h dark and fed ad libitum. All procedures involving
animals were in accordance with institutional ACUC-approved
protocols and with the Association for Research in Vision and
Ophthalmology (ARVO) guidelines for use of animals.
Electron microscopy
Standard procedures for thin-section transmission electron
microscopy (TEM) are previously described in detail [50]. A few
minor modifications of the procedure were used for mouse eyes.
Adult mice were perfused with 0.1 M phosphate buffered saline
followed by 2% glutaraldehyde/4% paraformaldehyde fixative in
cacodylate buffer (0.1 M, pH. 7.4). The eyes were dissected out.
After post-fixation, the cornea and lens were removed, marking
the orientation with a slit at the ventral pole. Eyes were rinsed
thoroughly with cacodylate buffer and post-fixed in 1% osmium
for 1 hr at room temperature, then dehydrated in graded ethanol
(e.g., 35%, 50%, 70%, 95%, and 100%) and propylene oxide
(100%). Eyes were infiltrated overnight in a 1:1 mixture of
propylene oxide and epoxy resin and embedded in pure resin and
cured at 55uC for 48 hrs. The cured block was trimmed and made
semi-thin sections (0.5 mm) and stained in Toluidine Blue-O
solution to determine proper orientation for thin-section EM
Figure 4. Loss of melanoregulin function partially rescues melanosome size and density in the choroid of Hps5ru2J mutant mice. A–I:
Electron microscopic images of the pigment choroid layer in mice of the genotypes indicated. Orientation is with RPE toward the top of each image.
Abbreviations: ru2J =Hps5ru2J; dsu =Mregdsu; WT =wildtype; Tg =MregTg ; Oa1 =Oa1ko. Scale bar = 1 mm.
doi:10.1371/journal.pone.0042446.g004
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analysis. Thin-sections (60 nm) were mounted on naked 200-mesh
copper grids, and stained in uranyl acetate and lead citrate. For
measuring the number and size of melanosomes, RPE and choroid
were imaged on a Hitachi H7000 (Tokyo, Japan) transmission
electron microscope at 30006 and images obtained with a Gatan
(Pleasanton, CA) digital camera and imaging software. For adults,
counts were made on a 40 mm2 area on 10–20 images from each
of 2–3 animals of each genotype. Counts on P5, P16, and P28
animals were done on 10 or more images from one animal of each
genotype at each age.
MREG localization in retinal sections and human ARPE19
cells
Immunohistochemistry was performed on frozen sections of 4-
month-old mouse retinas. The eyecups were fixed in 4%
paraformaldehyde in PBS (pH 7.4) overnight at 4uC, cryopro-
Figure 5. Melanoregulin levels influence melanosome characteristics in the choroid of Hps5ru2J and Oa1 mutant mice. Quantitation
and analysis of the data shown in Figure 4. Data points are mean values 6 SEM. A. Melanosome number and B. Melanosome area on an Oa1 null
background do not show a statistically significant change as a function of melanoregulin dose; all p values are p.0.05. In contrast, in Hps5ru2J mice,
both melanosome number and area increase, p,0.05. Mregdsu mice show a significant increase in melanosome area, p,0.05, with melanoregulin
over-expression (MregTg) and a decrease from wildtype in melanoregulin loss of function mice (Mregdsu), p,0.05, with no significant change in
number of melanosomes in either case, p.0.05. C. The number of pigmented melanosomes per field is compared to the average melanosomal area
in wildtype (C57Bl6/J) mice.
doi:10.1371/journal.pone.0042446.g005
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tected in 30% sucrose, and embedded in OCT. The 7 um sections
were stained with anti-MREG mAb (Novus Biologicals) at 1:200,
washed 36 and stained with secondary antibody Alexa 488 anti
mouse, dilution 1:500. Controls were incubated with the
secondary antibodies only. Nuclei were visualized with DAPI.
Images were captured on a Nikon A1R live cell confocal imaging
system. Data were analyzed using Nikon Elements AR Software
3.2.
ARPE19 cells grown on glass coverslips for 48 hours were rinse
in PBS and then fixed and permeabilized in 4% buffered
paraformaldehyde, with 0.2% Triton X100 for 10 minutes at
room temperature. After three successive washes in PBS with
0.05%Triton X100 (PBST) the coverslips were blocked in PBST
containing 4% Bovine serum albumin for 60 mins at 37uC. After
blocking, coverslips were incubated at 37u(-include degree
symbol)C for 60 minutes with primary antibodies: anti-MREG
mouse mAb, (Novus Biologics) 1:250, anti-alpha tubulin rabbit
pAb (Thermo) 1:200. After the incubation with primary antibod-
ies, the coverslips were washed 36 in PBST and then incubated
with secondary antibodies: Alexa Fluor 488 donkey anti-mouse
IgG (1:1000), Alexa Fluor 594 donkey anti-rabbit (1:1000) and
Hoechst 33258 (1:10,000) at 37uC for 60 minutes. Three
successive PBST washes followed the incubation with secondary
antibodies. In preparation for microscopy, the coverslips were
mounted in Cytoseal (Electron Microscopy Sciences). Images were
captured on a Nikon A1R laser scanning confocal microscope with
a 1006 oil objective and processes using Nikon’s Elements
software.
Statistical Analysis
Data are reported as the mean 6 SEM with statistical analysis
using a one-way ANOVA with appropriate post-hoc test. Results
with a p,0.05 were considered significant. Significance of analyses
is indicated in the figure legends.
Figure 6. Melanoregulin protein localizes to vesicle-like
structures in the RPE cytoplasm. A: Frozen 7 um sections of 4-
month-old mouse retinas were stained with anti-Mreg antibody. Nuclei
were visualized with DAPI. Images were captured on a Nikon A1R live
cell confocal imaging system. B: ARPE19 cells were fixed and stained
with anti-MREG mouse mAb, (Novus Biologics) 1:250, anti-alpha tubulin
rabbit pAb (Thermo) 1:200, washed and incubated with secondary
antibodies: Alexa Fluor 488 donkey anti- mouse IgG (1:1000), Alexa
Fluor 594 donkey anti-rabbit (1:1000) and Hoechst 33258 (1:10,000).
Images were captured on a Nikon A1R laser scanning confocal
microscope with a 1006 oil objective and processes using Nikon’s
Elements software.
doi:10.1371/journal.pone.0042446.g006
Figure 7. Model of melanoregulin function in melanosome biogenesis. These results are consistent with a hypothetical and testable model
in which melanoregulin functions as a negative regulator of vesicle fusion with cytoplasmic components required for melanosome biogenesis. The
panels in the diagrams are analogous to the panels in Figures 2 and 4, and show both a multivesicular body/endosome and a mature/pigmented
melanosome as two stages in the biogenesis of melanosomes. HPS BLOC-2 forms a putative vesicle transport complex, or part of a vesicle system
required for moving proteins required for melanosome biogenesis. Melanoregulin acts as a negative regulator of membrane fusion between BLOC-2
and the late endosome/early melanosome. Oa1 acts as a permissive gatekeeper, allowing components of melanosome biogenesis to accumulate up
to a certain point, at which time it initiates (or turns off) a signalling cascade that prevents further accumulation of pigment-producing components.
These features are compatible with the results presented here, and predict the results of future experiments that can be performed to test the tenets
of this model.
doi:10.1371/journal.pone.0042446.g007
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Supporting Information
Figure S1 Melanoregulin loss of function or overexpres-
sion have little effect on the size distribution of
melanosomes in either the RPE or choroid. Data
quantitated as shown in Figures 3D and 5D. The shape of the
curves is nearly identical in wildtype, melanoregulin loss of
function, and in melanoregulin overexpression. Data shown are an
average 6 SEM; differences are not statistically significant with
p.0.05.
(TIFF)
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